Neumora Therapeutics, Inc. Common Stock
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Neumora Therapeutics, Inc. Common Stock's balance sheet done over the years? Its assets were worth $496,195,000 last year, which is more than in the previous period. 5% of Neumora Therapeutics, Inc. Common Stock’s total assets is currently financed by debt. Its liabilities reached the amount of $27,119,000, which means an decrease by -97% compared compared to last year.

Debt to Assets

Neumora Therapeutics, Inc. Common Stock (NASDAQ:NMRA): Debt to assets
2019 0 21K Infinity%
2020 197946000 292.33M 147.68%
2021 429297000 754.51M 175.76%
2022 426234000 873.08M 204.84%
2023 496195000 27.11M 5.47%

NMRA Balance Sheet (2019 – 2023)

2023 2022 2021 2020 2019
Assets
Current assets:
Cash and cash equivalents
374.03M240.94M409.24M191.97M0
Short term investments
79.94M130.94M000
Net receivables
939K919K200K148K0
Inventory
00000
Other current assets
23.35M0000
Total current assets
478.27M387.95M415.60M193.84M0
Non-current assets:
Property, Plant and Equipment
6.85M10.64M4.04M3.92M0
Goodwill
00000
Intangible assets
00000
Long term investments
9.84M23.51M000
Other non-current assets
1.21M4.12M9.65M183K0
Total non-current assets
17.91M38.27M13.69M4.10M0
Total assets
496.19M426.23M429.29M197.94M0
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
011.53M19.09M5.59M0
Short term debt
6.75M3.37M1.05M764K0
Total current liabilities
25.11M23.69M23.27M9.37M21K
Non-current liabilities:
Long term debt
1.85M5.07M996K1.28M0
Deferred tax
00000
Other non-current liabilities
155K844.31M730.24M281.67M0
Total non-current liabilities
2.00M849.38M731.24M282.96M0
Total liabilities
27.11M873.08M754.51M292.33M21K
Data source